ARTICLE | Clinical News
Alphanate regulatory update
February 12, 2007 8:00 AM UTC
FDA approved an sBLA for Alphanate antihemophilic factor/ von Willebrand factor complex for patients undergoing surgery or invasive procedures with von Willebrand disease (vWD) in whom desmopressin i...